Athena Bitcoin Global (ABIT)
OTCMKTS · Delayed Price · Currency is USD
0.0199
+0.0001 (0.51%)
Aug 6, 2025, 3:58 PM EDT
Achilles Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Revenue | 276.61 | 285.39 | 191.81 | 73.69 | 81.75 | 68.94 | Upgrade |
Revenue Growth (YoY) | 10.74% | 48.79% | 160.30% | -9.86% | 18.58% | 204.45% | Upgrade |
Cost of Revenue | 242.02 | 245.61 | 162.18 | 58.67 | 76.13 | 62.36 | Upgrade |
Gross Profit | 34.59 | 39.78 | 29.62 | 15.02 | 5.61 | 6.58 | Upgrade |
Selling, General & Admin | 13.11 | 12.41 | 6.26 | 6.38 | 4.8 | 3.36 | Upgrade |
Research & Development | 1.61 | 1.35 | 0.98 | 0.78 | 0.14 | 0.09 | Upgrade |
Other Operating Expenses | 0.65 | 1.15 | 0.43 | 0.06 | 0.23 | 0.06 | Upgrade |
Operating Expenses | 16.16 | 15.71 | 7.67 | 7.21 | 5.17 | 3.5 | Upgrade |
Operating Income | 18.42 | 24.07 | 21.95 | 7.8 | 0.44 | 3.09 | Upgrade |
Interest Expense | -1.02 | -1.88 | -2.38 | -0.69 | -0.66 | -0.99 | Upgrade |
Other Non Operating Income (Expenses) | -2.23 | -2.39 | -1.06 | -0.25 | -0.9 | -1.63 | Upgrade |
EBT Excluding Unusual Items | 15.18 | 19.8 | 18.51 | 6.87 | -1.12 | 0.47 | Upgrade |
Asset Writedown | -1.78 | -1.78 | -2.82 | -0.97 | -0.04 | -0.04 | Upgrade |
Legal Settlements | -3 | -3 | - | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | -1.6 | 0.16 | Upgrade |
Pretax Income | 10.4 | 15.02 | 15.69 | 5.89 | -2.76 | 0.59 | Upgrade |
Income Tax Expense | 3.54 | 4.73 | 4.49 | 1.77 | 0.88 | 0.43 | Upgrade |
Net Income | 6.86 | 10.28 | 11.2 | 4.12 | -3.64 | 0.16 | Upgrade |
Net Income to Common | 6.86 | 10.28 | 11.2 | 4.12 | -3.64 | 0.16 | Upgrade |
Net Income Growth | -60.04% | -8.15% | 171.48% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 4,125 | 4,095 | 3,975 | 3,967 | 4,049 | 3,841 | Upgrade |
Shares Outstanding (Diluted) | 4,466 | 4,466 | 4,464 | 4,475 | 4,049 | 4,080 | Upgrade |
Shares Change (YoY) | -1.98% | 0.06% | -0.25% | 10.51% | -0.74% | 227.00% | Upgrade |
EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | Upgrade |
EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | Upgrade |
EPS Growth | -46.06% | -8.04% | 155.69% | - | - | - | Upgrade |
Free Cash Flow | 8.78 | 10.9 | 13.83 | -0.12 | -6.37 | -6.92 | Upgrade |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | - | -0.00 | -0.00 | Upgrade |
Gross Margin | 12.50% | 13.94% | 15.44% | 20.38% | 6.87% | 9.55% | Upgrade |
Operating Margin | 6.66% | 8.43% | 11.45% | 10.59% | 0.54% | 4.47% | Upgrade |
Profit Margin | 2.48% | 3.60% | 5.84% | 5.60% | -4.46% | 0.23% | Upgrade |
Free Cash Flow Margin | 3.17% | 3.82% | 7.21% | -0.16% | -7.79% | -10.03% | Upgrade |
EBITDA | 23.43 | 28.17 | 23.43 | 9.47 | 1.02 | 3.37 | Upgrade |
EBITDA Margin | 8.47% | 9.87% | 12.22% | 12.86% | 1.25% | 4.89% | Upgrade |
D&A For EBITDA | 5 | 4.1 | 1.48 | 1.67 | 0.58 | 0.28 | Upgrade |
EBIT | 18.42 | 24.07 | 21.95 | 7.8 | 0.44 | 3.09 | Upgrade |
EBIT Margin | 6.66% | 8.43% | 11.45% | 10.59% | 0.54% | 4.47% | Upgrade |
Effective Tax Rate | 34.03% | 31.52% | 28.62% | 30.03% | - | 72.79% | Upgrade |
Advertising Expenses | - | 0.06 | 0.05 | 0.05 | 0.37 | 0.15 | Upgrade |
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.